Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Dermata Therapeutics, Inc.

NASDAQ: DRMA · Life Sciences · 4 alerts · CIK 1853816

Share price
$0.5985Close, Nov 16
Market cap
$2.95M
Shares outstanding
4.93MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Dermata Therapeutics, Inc. filings on SEC EDGAR ↗

8:31 AM ET 8-K
Business Update

Dermata Therapeutics Business Update

Dermata Therapeutics released additional results and photos from its recently completed cosmetic clinical study of Tome Foundational Treatment. The company also announced it has received over 1,000 orders for the skin renewal treatment since its recent commercial launch.

5:26 PM ET 8-K
Business Update

Dermata Therapeutics Business Update

Dermata Therapeutics announced the enrollment of the first participant in a clinical trial for Tome Clearing Treatment, its once-weekly acne treatment. The company expects to launch this product commercially in the first half of 2027 as part of its strategic shift toward skincare products.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.